FerroKin BioSciences, Inc.

Imago BioSciences, Inc. revealed on 19 November that it raised $80m in series C venture capital to fund the first Phase III clinical trial for its lysine-specific demethylase 1 (LSD1 or KDM1A) inhibi

Financings In the first quarter of 2012, biopharma start-ups raised $338.1 million – 51% less than the previous quarter but a 62% hike from Q1 2011. Series B rounds dominated, generating 43% of the to

Financings The first quarter of 2012 featured $3.7 billion in biopharma financing, $1 billion more than Q4 2011’s total, but on pace with the opening quarter of last year, in which $3.6 billion was ra

Exhibit 1 Top Alliances In March 2012 *Potential Deal Value is the sum of up-front fees plus pre-commercialization money. Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisition In March